The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma

Cxbladder (Cxb) tests combine genomic biomarkers in urine with phenotypic and clinical data to classify hematuria patients into those at low/high probability of urothelial carcinoma (UC). Cxbladder Resolve (CxbR) is designed for use after Cxb Triage (CxbT) and Detect (CxbD), where CxbT-positive test...

Descripción completa

Detalles Bibliográficos
Autores principales: Raman, Jay D., Kavalieris, Laimonis, Konety, Badrinath, Porten, Sima, Daneshmand, Siamak, Lotan, Yair, Loo, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Adult Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584223/
https://www.ncbi.nlm.nih.gov/pubmed/34348469
http://dx.doi.org/10.1097/JU.0000000000002135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584223/
https://www.ncbi.nlm.nih.gov/pubmed/34348469
http://dx.doi.org/10.1097/JU.0000000000002135

Ejemplares similares